Stockholm, January 19, 2020 — Elsa Science, a Swedish company delivering digital therapeutics, initially to patients with autoimmune rheumatic diseases, is excited to announce their new investment of 2M€ led by Norrsken Foundation with participation by new investors Noaber Foundation, Per Båtelson, Ahsan Amjad, Josefin Landgård and existing investors Inventure…